Open Access. Powered by Scholars. Published by Universities.®
Biomedical Engineering and Bioengineering Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Alzheimer’s disease (1)
- Astrocyte (1)
- Brain (1)
- Computer-aided diagnosis (1)
- Cortex (1)
-
- Cortical Column (1)
- Deconvolution (1)
- Dimensionality reduction (1)
- Fractional Volume Analysis (1)
- Mild cognitive impairment (MCI) (1)
- Motor (1)
- Multiclass classification (1)
- Multimodal analysis (1)
- Natural language processing (NLP) (1)
- Neuron (1)
- Nuclei (1)
- Nuclei Classification (1)
- Somatosensory (1)
- Vasculature (1)
Articles 1 - 2 of 2
Full-Text Articles in Biomedical Engineering and Bioengineering
3d Architectural Analysis Of Neurons, Astrocytes, Vasculature & Nuclei In The Motor And Somatosensory Murine Cortical Columns, Jared Leichner
3d Architectural Analysis Of Neurons, Astrocytes, Vasculature & Nuclei In The Motor And Somatosensory Murine Cortical Columns, Jared Leichner
FIU Electronic Theses and Dissertations
Characterization of the complex cortical structure of the brain at a cellular level is a fundamental goal of neuroscience which can provide a better understanding of both normal function as well as disease state progression. Many challenges exist however when carrying out this form of analysis. Immunofluorescent staining is a key technique for revealing 3-dimensional structure, but subsequent fluorescence microscopy is limited by the quantity of simultaneous targets that can be labeled and intrinsic lateral and isotropic axial point-spread function (PSF) blurring during the imaging process in a spectral and depth-dependent manner. Even after successful staining, imaging and optical deconvolution, …
Development Of Gaussian Learning Algorithms For Early Detection Of Alzheimer's Disease, Chen Fang
Development Of Gaussian Learning Algorithms For Early Detection Of Alzheimer's Disease, Chen Fang
FIU Electronic Theses and Dissertations
Alzheimer’s disease (AD) is the most common form of dementia affecting 10% of the population over the age of 65 and the growing costs in managing AD are estimated to be $259 billion, according to data reported in the 2017 by the Alzheimer's Association. Moreover, with cognitive decline, daily life of the affected persons and their families are severely impacted. Taking advantage of the diagnosis of AD and its prodromal stage of mild cognitive impairment (MCI), an early treatment may help patients preserve the quality of life and slow the progression of the disease, even though the underlying disease cannot …